Literature DB >> 10535605

HIV infection and pathogenesis: what about chemokines?

R C Gallo1, A Garzino-Demo, A L DeVico.   

Abstract

Several chemotactic cytokines, or chemokines. inhibit HIV replication by blocking or down regulating chemokine receptors that serve as entry cofactors for the virus. Although the role of chemokine receptors in HIV pathogenesis has been the subject of intense interest, chemokines are comparatively less seriously considered as potential correlates of protection from HIV infection and disease progression. However, a critical analysis of newly available data reveals substantial evidence to support a beneficial role for chemokines in HIV infection and disease. In this review we summarize the results of such studies and their promising implications for HIV infection.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10535605     DOI： 10.1023/a:1020539524373

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


  68 in total

1.  Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage.

Authors:  M H Klinger; D Wilhelm; S Bubel; M Sticherling; J M Schröder; W Kühnel
Journal:  Int Arch Allergy Immunol       Date:  1995-08       Impact factor: 2.749

2.  beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.

Authors:  J L Heeney; V J Teeuwsen; M van Gils; W M Bogers; C De Giuli Morghen; A Radaelli; S Barnett; B Morein; L Akerblom; Y Wang; T Lehner; D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

3.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

4.  Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients.

Authors:  G Hittinger; C Poggi; E Delbeke; N Profizi; A Lafeuillade
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

5.  Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

Authors:  S Struyf; I De Meester; S Scharpé; J P Lenaerts; P Menten; J M Wang; P Proost; J Van Damme
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

6.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

8.  Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection.

Authors:  R B Moss; R J Trauger; W K Giermakowska; J L Turner; M R Wallace; F C Jensen; S P Richieri; F Ferre; A E Daigle; C Duffy; G Theofan; D J Carlo
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-04-01

9.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728
View more
  11 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.

Authors:  Fiorenza Cocchi; Anthony L DeVico; Wuyuan Lu; Mikulas Popovic; Olga Latinovic; Mohammad M Sajadi; Robert R Redfield; Mark K Lafferty; Massimo Galli; Alfredo Garzino-Demo; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 3.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  The impact of viral and host elements on HIV fitness and disease progression.

Authors:  Kenneth R Henry; Jan Weber; Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

5.  Modulating influence on HIV/AIDS by interacting RANTES gene variants.

Authors:  Ping An; George W Nelson; Lihua Wang; Sharyne Donfield; James J Goedert; John Phair; David Vlahov; Susan Buchbinder; William L Farrar; William Modi; Stephen J O'Brien; Cheryl A Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

6.  Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women.

Authors:  Iain J MacLeod; Christopher F Rowley; Shahin Lockman; Anthony Ogwu; Sikhulile Moyo; Erik van Widenfelt; Mompati Mmalane; Joseph Makhema; M Essex; Roger L Shapiro
Journal:  J Int AIDS Soc       Date:  2012-07-10       Impact factor: 5.396

Review 7.  Genetic correlates influencing immunopathogenesis of HIV infection.

Authors:  Gaurav Sharma; Gurvinder Kaur; Narinder Mehra
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

8.  Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Sudheesh Pilakka-Kanthikeel; Shailendra K Saxena; Zainulabedin Saiyed; Madhavan P N Nair
Journal:  AIDS Res Treat       Date:  2012-05-20

Review 9.  Host factors influencing susceptibility to HIV infection and AIDS progression.

Authors:  Juan Lama; Vicente Planelles
Journal:  Retrovirology       Date:  2007-07-25       Impact factor: 4.602

10.  Retrospective Proteomic Analysis of Cellular Immune Responses and Protective Correlates of p24 Vaccination in an HIV Elite Controller Using Antibody Arrays.

Authors:  Suneth S Perera; Bin Wang; Arturo Damian; Wayne Dyer; Li Zhou; Viviane Conceicao; Nitin K Saksena
Journal:  Microarrays (Basel)       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.